메뉴보기
    HOME

    SEARCH

    • up
    • down
    [PUBLICATIONS] Kim A, Dueker S, Dong F, Roffel AF, Lee S, Lee H. Human ADME for YH12852 using wavelength scanning cavity ring-down spectroscopy (WS-CRDS) after a low radioactivity dose. Bioanalysis. 2020 Jan;12(2):87-98. doi:10.4155/bio-2019-0119
    [NEWS] 2020 Winter Smart Internship
    [PUBLICATIONS] Drelichman G, Castaneda-Hernandez G, Ar C, Dragosky M, Garcia R, Lee H, Moiseev S, Naderi M, Rosenbaum H, Znidar I, Zuluaga AF, Freisens S, Mistry PK. The Road to Biosimilars in Rare Diseases - Ongoing Lessons from Gaucher Disease. Am J Hematol. 2020 Mar;95(3):233-237; doi:10.1002/ajh.25701 [Epub 2019 Dec 3]
    [NEWS] CCADD Workshop 2019
    [PUBLICATIONS] Oh J, Huh KY,  Cho YG, Cha JE, Kim SJ, Yoon SH, Park SS, Yoon H, Lee J, Lee H. Safety, tolerability and pharmacokinetics and pharmacodynamics of HL2351, a novel hybrid Fc-fused IL-1 receptor antagonist, in healthy subjects: a first-in-human study. Br J Clinical Pharmacol. 2020 Feb;86(2):372-379 doi: 10.1111/bcp.14161. [Epub 2020 Jan 3]

    CCADD

    Center for Convergence Approaches in Drug Development, Graduate School of Convergence Science and Technology, Seoul National University

    Room C-208, 145 Gwanggyo-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, 16229, SOUTH KOREA (Gwanggyo)

    Room 406, Building 17, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, SOUTH KOREA (Yeon-gun)

    Tel: +82-31-888-9189 (Gwanggyo); +82-2-3668-7381 (Yeon-gun)

    Fax: +82-31-888-9575

    Email: ccadd.snu@gmail.com